PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic Function

NCT06048302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Healthy

Interventions

DRUG: Obicetrapib

Sponsor

NewAmsterdam Pharma

Collaborators

[object Object]